Cargando…
RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer
Gene expression microarrays have identified many tumor markers and therapeutic targets for pancreatic ductal adenocarcinoma (PDAC). However, microarray profilings have limited sensitivity and are prone to cross-hybridization between homologous DNA fragments. Here, we perform a transcriptome analysis...
Autores principales: | Mao, Yixiang, Shen, Jianjun, Lu, Yue, Lin, Kevin, Wang, Huamin, Li, Yanan, Chang, Ping, Walker, Mary G., Li, Donghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522086/ https://www.ncbi.nlm.nih.gov/pubmed/28418924 http://dx.doi.org/10.18632/oncotarget.16451 |
Ejemplares similares
-
Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
por: Javle, Milind, et al.
Publicado: (2014) -
Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer
por: Luo, Zhaofan, et al.
Publicado: (2015) -
Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
por: Mao, Yixiang, et al.
Publicado: (2015) -
Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer
por: Liu, Chang, et al.
Publicado: (2016) -
Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2021)